Boston Scientific Corp (BSX)
91.50
+1.33
(+1.48%)
USD |
NYSE |
Nov 21, 16:00
91.40
-0.10
(-0.11%)
Pre-Market: 05:18
Boston Scientific Total Liabilities (Quarterly): 17.12B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 17.12B |
June 30, 2024 | 16.50B |
March 31, 2024 | 16.50B |
December 31, 2023 | 15.61B |
September 30, 2023 | 14.91B |
June 30, 2023 | 15.12B |
March 31, 2023 | 14.78B |
December 31, 2022 | 14.90B |
September 30, 2022 | 14.31B |
June 30, 2022 | 14.94B |
March 31, 2022 | 15.60B |
December 31, 2021 | 15.61B |
September 30, 2021 | 15.42B |
June 30, 2021 | 15.23B |
March 31, 2021 | 15.18B |
December 31, 2020 | 15.45B |
September 30, 2020 | 15.28B |
June 30, 2020 | 15.21B |
March 31, 2020 | 16.31B |
December 31, 2019 | 16.69B |
September 30, 2019 | 17.06B |
June 30, 2019 | 14.88B |
March 31, 2019 | 14.57B |
December 31, 2018 | 12.27B |
September 30, 2018 | 12.09B |
Date | Value |
---|---|
June 30, 2018 | 11.87B |
March 31, 2018 | 12.17B |
December 31, 2017 | 12.03B |
September 30, 2017 | 11.05B |
June 30, 2017 | 11.15B |
March 31, 2017 | 10.89B |
December 31, 2016 | 11.36B |
September 30, 2016 | 11.22B |
June 30, 2016 | 11.62B |
March 31, 2016 | 11.26B |
December 31, 2015 | 11.81B |
September 30, 2015 | 11.80B |
June 30, 2015 | 10.54B |
March 31, 2015 | 9.971B |
December 31, 2014 | 10.57B |
September 30, 2014 | 10.02B |
June 30, 2014 | 9.933B |
March 31, 2014 | 9.801B |
December 31, 2013 | 10.03B |
September 30, 2013 | 10.35B |
June 30, 2013 | 10.39B |
March 31, 2013 | 10.26B |
December 31, 2012 | 10.28B |
September 30, 2012 | 10.07B |
June 30, 2012 | 10.09B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.31B
Minimum
Sep 2022
17.12B
Maximum
Sep 2024
15.53B
Average
15.35B
Median
Total Liabilities (Quarterly) Benchmarks
Baxter International Inc | 18.73B |
Haemonetics Corp | 1.646B |
ResMed Inc | 2.027B |
Globus Medical Inc | 1.017B |
Abbott Laboratories | 34.33B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 38.08B |
Shareholders Equity (Quarterly) | 20.71B |
Debt to Equity Ratio | 0.5254 |
Current Ratio | 1.482 |
Net Debt Paydown Yield | -0.30% |